Time-dependent changes of plasma adiponectin concentration in relation to coronary microcirculatory function in patients with acute myocardial infarction treated by primary percutaneous coronary intervention

Journal of Cardiology

Volumn 65, Issue 3, 2015, Pages 208-215

  Trifunovic, Danijela ^a,b   Stankovic, Sanja ^b   Marinkovic, Jelena ^b   Beleslin, Branko ^a,b   Banovic, Marko ^a   Djukanovic, Nina ^a   Orlic, Dejan ^a,b   Tesic, Milorad ^a   Vujisic Tesic, Bosiljka ^a,b   Petrovic, Milan ^a,b   Nedeljkovic, Ivana ^a,b   Stepanovic, Jelena ^a,b   Djordjevic Dikic, Ana ^a,b   Giga, Vojislav ^a,b   Ostojic, Miodrag ^b  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Adiponectin; Coronary microcirculation; ST segment elevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ADIPONECTIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CLOPIDOGREL; CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE; TRIACYLGLYCEROL; TROPONIN I; ADIPOQ PROTEIN, HUMAN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD VESSEL INJURY; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY FLOW RESERVE; CORONARY MICROCIRCULATION FUNCTION; CORONARY REPERFUSION; CORRELATIONAL STUDY; CYTOKINE RESPONSE; DISEASE ASSOCIATION; ENZYME KINETICS; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; MIDDLE AGED; PATIENT RISK; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBECTOMY; TIME TO TREATMENT; ADVERSE EFFECTS; AGED; BLOOD; CORONARY ARTERY BLOOD FLOW; MYOCARDIAL INFARCTION; ODDS RATIO; TIME;

ADIPONECTIN; AGED; CORONARY CIRCULATION; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; TIME FACTORS;

EID: 84924285591     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.05.011     Document Type: Article

References (44)

1. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg P.G., James S.K., Atar D., Badano L.P., Blömstrom-Lundqvist C., Borger M.A., Di Mario C., Dickstein K., Ducrocq G., Fernandez-Aviles F., Gershlick A.H., Giannuzzi P., Halvorsen S., Huber K., et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012, 33:2569-2619.
2. Lerman A., Holmes D.R., Herrmann J., Gersh B.J. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?. Eur Heart J 2007, 28:788-797.
3. Niccoli G., Burzotta F., Galiuto L., Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol 2009, 54:281-292.
4. Vaiopoulos A.G., Marinou K., Christodoulides C., Koutsilieris M. The role of adiponectin in human vascular physiology. Int J Cardiol 2012, 155:188-193.
5. Devaraj S., Torok N., Dasu M.R., Samols D., Jialal I. Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol 2008, 28:1368-1374.
6. Antonopoulos A.S., Lee R., Margaritis M., Antoniades C. Adiponectin as a regulator of vascular redox state: therapeutic implications. Recent Pat Cardiovasc Drug Discov 2011, 6:78-88.
7. Ntaios G., Gatselis N.K., Makaritsis K., Dalekos G.N. Adipokines as mediators of endothelial function and atherosclerosis. Atherosclerosis 2013, 227:216-221.
8. Eroglu S., Sade L.E., Bozbas H., Haberal A., Ozbicer S., Demir O., Muderrisoglu H. Association of serum adiponectin levels and coronary flow reserve in women with normal coronary angiography. Eur J Cardiovasc Prev Rehabil 2009, 16:290-296.
9. Date H., Imamura T., Ideguchi T., Kawagoe J., Sumi T., Masuyama H., Onitsuka H., Ishikawa T., Nagoshi T., Eto T. Adiponectin produced in coronary circulation regulates coronary flow reserve in nondiabetic patients with angiographically normal coronary arteries. Clin Cardiol 2006, 29:211-214.
10. Sade L.E., Eroglu S., Bozbaş H., Ozbiçer S., Hayran M., Haberal A., Müderrisoğlu H. Relation between epicardial fat thickness and coronary flow reserve in women with chest pain and angiographically normal coronary arteries. Atherosclerosis 2009, 204:580-585.
11. Okui H., Hamasaki S., Ishida S., Kataoka T., Orihara K., Fukudome T., Ogawa M., Oketani N., Saihara K., Shinsato T., Shirasawa T., Mizoguchi E., Kubozono T., Ichiki H., Ninomiya Y., et al. Adiponectin is a better predictor of endothelial function of the coronary artery than HOMA-R, body mass index, immunoreactive insulin, or triglycerides. Int J Cardiol 2008, 126:53-61.
12. Giannessi D., Caselli C., Del Ry S., Maltinti M., Pardini S., Turchi S., Cabiati M., Sampietro T., Abraham N., L'abbate A., Neglia D. Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure. Metabolism 2011, 60:227-233.
13. Kondo K., Shibata R., Unno K., Shimano M., Ishii M., Kito T., Shintani S., Walsh K., Ouchi N., Murohara T. Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model. Circ Cardiovasc Interv 2010, 3:166-173.
14. Pischon T., Hu F.B., Girman C.J., Rifai N., Manson J.E., Rexrode K.M., Rimm E.B. Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women. Atherosclerosis 2011, 219:322-329.
15. Ai M., Otokozawa S., Asztalos B.F., White C.C., Cupples L.A., Nakajima K., Lamon-Fava S., Wilson P.W., Matsuzawa Y., Schaefer E.J. Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring study. Atherosclerosis 2011, 217:543-548.
16. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004, 291:1730-1737.
17. Kojima S., Funahashi T., Otsuka F., Maruyoshi H., Yamashita T., Kajiwara I., Shimomura H., Miyao Y., Fujimoto K., Sugiyama S., Sakamoto T., Yoshimura M., Ogawa H. Future adverse cardiac events can be predicted by persistently low plasma adiponectin concentrations in men and marked reductions of adiponectin in women after acute myocardial infarction. Atherosclerosis 2007, 194:204-213.
18. Shibata R., Numaguchi Y., Matsushita K., Sone T., Kubota R., Ohashi T., Ishii M., Kihara S., Walsh K., Ouchi N., Murohara T. Usefulness of adiponectin to predict myocardial salvage following successful reperfusion in patients with acute myocardial infarction. Am J Cardiol 2008, 101:1712-1715.
19. Cavusoglu E., Ruwende C., Chopra V., Yanamadala S., Eng C., Clark L.T., Pinsky D.J., Marmur J.D. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 2006, 27:2300-2309.
20. Lindberg S., Pedersen S.H., Møgelvang R., Bjerre M., Frystyk J., Flyvbjerg A., Galatius S., Jensen J.S. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol 2012, 109:492-496.
21. Kojima S., Funahashi T., Sakamoto T., Miyamoto S., Soejima H., Hokamaki J., Kajiwara I., Sugiyama S., Yoshimura M., Fujimoto K., Miyao Y., Suefuji H., Kitagawa A., Ouchi N., Kihara S., et al. The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart 2003, 89:667.
22. Saraste M., Koskenvuo J., Knuuti J., Toikka J., Laine H., Niemi P., Sakuma H., Hartiala J. Coronary flow reserve: measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. Clin Physiol 2001, 21:114-122.
23. Djordjevic-Dikic A., Beleslin B., Stepanovic J., Giga V., Tesic M., Dobric M., Stojkovic S., Nedeljkovic M., Vukcevic V., Dikic N., Petrasinovic Z., Nedeljkovic I., Tomasevic M., Vujisic-Tesic B., Ostojic M. Prediction of myocardial functional recovery by noninvasive evaluation of basal and hyperemic coronary flow in patients with previous myocardial infarction. J Am Soc Echocardiogr 2011, 24:573-581.
24. Rigo F., Varga Z., Di Pede F., Grassi G., Turiano G., Zuin G., Coli U., Raviele A., Picano E. Early assessment of coronary flow reserve by transthoracic Doppler echocardiography predicts late remodeling in reperfused anterior myocardial infarction. J Am Soc Echocardiogr 2004, 17:750-755.
25. Meimoun P., Boulanger J., Luycx-Bore A., Zemir H., Elmkies F., Malaquin D., Doutrelan L., Tribouilloy C. Non-invasive coronary flow reserve after successful primary angioplasty for acute anterior myocardial infarction is an independent predictor of left ventricular adverse remodeling. Eur J Echocardiogr 2010, 11:711-718.
26. Report of a WHO/IDF Consultation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. http://whqlibdoc.who.int/publications.
27. Levey A.S., Coresh J., Greene T., Stevens L.A., Zhang Y.L., Hendriksen S., Kusek J.W., Van Lente F., Chronic Kidney Disease Epidemiology Collaboration Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145:247-254.
28. Sheehan F.H., Braunwald E., Canner P., Dodge H.T., Gore J., Van Natta P., Passamani E.R., Williams D.O., Zaret B. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. Circulation 1987, 75:817-829.
29. Vanhaecke J., Flameng W., Borgers M., Jang I.K., Van de Werf F., De Geest H. Evidence for decreased coronary flow reserve in viable postischemic myocardium. Circ Res 1990, 67:1201-1210.
30. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
31. Kojima S., Kojima S., Maruyoshi H., Nagayoshi Y., Kaikita K., Sumida H., Sugiyama S., Funahashi T., Ogawa H. Hypercholesterolemia and hypoadiponectinemia are associated with necrotic core-rich coronary plaque. Int J Cardiol 2011, 147:371-376.
32. Ohara T., Hashimura K., Asakura M., Ogai A., Amaki M., Hasegawa T., Kanzaki H., Sonoda M., Nishizawa H., Funahashi T., Kitakaze M. Dynamic changes in plasma total and high molecular weight adiponectin levels in acute heart failure. J Cardiol 2011, 58:181-189.
33. Beatty A.L., Zhang M.H., Ku I.A., Na B., Schiller N.B., Whooley M.A. Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the Heart and Soul Study. Atherosclerosis 2012, 220:587-592.
34. Shibata R., Sato K., Kumada M., Izumiya Y., Sonoda M., Kihara S., Ouchi N., Walsh K. Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment. Cardiovasc Res 2007, 74:471-479.
35. Ohashi K., Ouchi N., Matsuzawa Y. Adiponectin and hypertension. Am J Hypertens 2011, 24:263-269.
36. Matsuzawa Y. Adiponectin: a key player in obesity related disorders. Curr Pharm Des 2010, 16:1896-1901.
37. Xita N., Tsatsoulis A. Adiponectin in diabetes mellitus. Curr Med Chem 2012, 19:5451-5458.
38. Ouchi N., Kihara S., Funahashi T., Nakamura T., Nishida M., Kumada M., Okamoto Y., Ohashi K., Nagaretani H., Kishida K., Nishizawa H., Maeda N., Kobayashi H., Hiraoka H., Matsuzawa Y. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003, 107:671-674.
39. Nakamura K., Fuster J.J., Walsh K. Adipokines: a link between obesity and cardiovascular disease. J Cardiol 2014, 63:250-259.
40. Fernández-Real J.M., Castro A., Vázquez G., Casamitjana R., López-Bermejo A., Peñarroja G., Ricart W. Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes Care 2004, 27:739-745.
41. Santagata P., Rigo F., Gherardi S., Pratali L., Drozdz J., Varga A., Picano E. Clinical and functional determinants of coronary flow reserve in non-ischemic dilated cardiomyopathy: an echocardiographic study. Int J Cardiol 2005, 105:46-52.
42. Vanderheyden M., Bartunek J., Verstreken S., Mortier L., Goethals M., de Bruyne B. Non-invasive assessment of coronary flow reserve in idiopathic dilated cardiomyopathy: hemodynamic correlations. Eur J Echocardiogr 2005, 6:47-53.
43. Hozumi T., Yoshida K., Akasaka T., Asami Y., Ogata Y., Takagi T., Kaji S., Kawamoto T., Ueda Y., Morioka S. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol 1998, 32:1251-1259.
44. Lara-Castro C., Luo N., Wallace P., Klein R.L., Garvey W.T. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006, 55:249-259.